Negative prognostic genes such as OLFML2B may promote the adhesion of OV cells to certain components in the ECM through their surface receptors and activate the expression of metalloproteinases to degrade the matrix, thereby promoting cancer progression. This evidence concerns the gene OLFML2B and cancer.